Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CareRx (TSE:CRRX)
TSX:CRRX
CRRX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$1.45 - C$2.78
Previous CloseN/A
Volume3.32K
Average Volume (3M)42.60K
Market Cap
C$170.74M
Enterprise ValueC$190.79M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.33
Next Earnings
Mar 06, 2025EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding62,138,870
10 Day Avg. Volume94,577
30 Day Avg. Volume42,600
Standard Deviation2.28
R-Squared0.00314
Alpha0.28
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.45
Price to Cash Flow (P/CF)5.10
P/FCF Ratio4.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$3.50Price Target Upside27.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
---
CareRx News
PremiumCompany Announcements
CareRx Simplifies Balance Sheet with Debenture Conversion
PremiumCompany Announcements
CareRx Reports Strong Q3 Growth and Expansion Plans
PremiumCompany Announcements
CareRx Unveils High-Tech Pharmacy in British ColumbiaPremiumCompany Announcements
CareRx Welcomes New CFO Suzanne Brand
PremiumCompany Announcements
CareRx Approved for Stock Buyback Program
PremiumCompany Announcements
CareRx Q2 2024: Revenue Up, Adjusted EBITDA Grows
PremiumCompany Announcements
CareRx Reveals Q2 2024 Financial Performance---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMargins are rising, which could benefit the company in the future.
Financial StabilityDebt is decreasing, which may improve the company's financial stability.
Growth PotentialThe company beat consensus topline expectations, showing potential for growth.
Bears Say
EarningsThe financial results came in below the analyst's estimates.
Operational ChallengesConsensus EBITDA estimates were not met, indicating potential challenges.
Revenue DeclineRevenues declined 3% year-over-year due to a net reduction in beds serviced.
---
Options Prices
Currently, No data available
---
Ownership Overview
CRRX FAQ
What was CareRx’s price range in the past 12 months?
CareRx lowest stock price was C$1.45 and its highest was C$2.78 in the past 12 months.
What is CareRx’s market cap?
CareRx’s market cap is C$170.74M.
When is CareRx’s upcoming earnings report date?
CareRx’s upcoming earnings report date is Mar 06, 2025 which is in 11 days.
How were CareRx’s earnings last quarter?
CareRx released its earnings results on Nov 08, 2024. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of C$0.013 by -C$0.023.
Is CareRx overvalued?
According to Wall Street analysts CareRx’s price is currently Undervalued.
Does CareRx pay dividends?
CareRx does not currently pay dividends.
What is CareRx’s EPS estimate?
CareRx’s EPS estimate is 0.02.
How many shares outstanding does CareRx have?
CareRx has 62,138,870 shares outstanding.
What happened to CareRx’s price movement after its last earnings report?
CareRx reported an EPS of -C$0.01 in its last earnings report, missing expectations of C$0.013. Following the earnings report the stock price went up 4.396%.
Which hedge fund is a major shareholder of CareRx?
Currently, no hedge funds are holding shares in TSE:CRRX
---
CareRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$3.50 (27.27% Upside)
C$3.50 (27.27% Upside)
Insider Transactions
Bought Shares
Worth C$21.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
74.05%
12-Months-Change
Fundamentals
Return on Equity
-7.50%
Trailing 12-Months
Asset Growth
-17.07%
Trailing 12-Months
Company Description
CareRx
CareRx Corp is a provider of specialty pharmacy services to seniors. It serves more than 50,000 residents in over 850 seniors and other communities (long-term care homes, retirement homes, assisted living facilities, and group homes). The company is a national organization with a large network of pharmacy fulfillment centres strategically located across the country. This allows it to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. It takes an active role in working with its home operator partners to promote resident health, staff education, and medication system quality and efficiency.
---
CRRX Stock 12 Month Forecast
Average Price Target
C$3.50
▲(27.27% Upside)
Technical Analysis
Best Analysts Covering CRRX
1 Year
1 Year Success Rate
4/14 ratings generated profit
1 Year Average Return
-10.82%
reiterated a buy rating 10 months ago
Copying Stefan Quenneville's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -10.82% per trade.
---